Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 3468-3472, October 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pamukcu, A. M.
Right arrow Articles by Bryan, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pamukcu, A. M.
Right arrow Articles by Bryan, G. T.

Quercetin, a Rat Intestinal and Bladder Carcinogen Present in Bracken Fern (Pteridium aquilinum)1

A. Mahir Pamukcu2, Senay Yalçiner, James F. Hatcher and George T. Bryan

Division of Clinical Oncology, Department of Human Oncology, Wisconsin Clinical Cancer Center, Madison, Wisconsin 53792 [A. M. P., J. F. H., G. T. B.], and Department of Pathological Anatomy, College of Veterinary Medicine, University of Ankara, Ankara, Turkey [A. M. P., S. Y.]

Albino noninbred weanling male and female rats were fed a basic grain diet (Group 1) or a basic diet supplemented with 33% bracken fern [BF (Group 2)] or 0.1% quercetin [purity, >99% (Group 3)] for 58 weeks. The quantities of quercetin and kaempferol (a close structural analog) in BF as glycosides were determined to be 0.57 and 1.1 g, respectively, per kg of dried BF. Estimated mean total cumulative doses (mmol) per rat were: Group 1, quercetin, males and females < 0.03; kaempferol, males and females < 0.03; Group 2, quercetin, males 5.8, females 5.2; kaempferol, males 11.9, females 10.8; and Group 3, quercetin, males 27.8, females 25.3; kaempferol, males and females < 0.03. Growth of rats fed BF or quercetin was comparable but significantly (p < 0.01) slower after 24 weeks than that of Group 1. Mean survivals (weeks) of rats of all groups were: Group 1, 58 ± 7 (S.D.); Group 2, 51 ± 13; and Group 3, 56 ± 8. They were not significantly different, although rats fed BF tended to die earlier secondary to intestinal tumor-induced intussusception and obstruction. The following incidences of intestinal or bladder neoplasms in male or female rats, respectively, were observed: Group 1, intestinal and bladder, males, 0 of 9, females, 0 of 10; Group 2, intestinal, males, 7 of 8, females, 10 of 11; bladder, males, 6 of 8, females, 8 of 11; Group 3, intestinal, males, 6 of 7, females, 14 of 18; bladder, males, 2 of 7, females, 3 of 18. The histopathology of neoplasms of the 2 target organs was identical for rats of Groups 2 and 3. Multiple ileal intestional neoplasms of rats fed quercetin included: adenoma, 4; fibroadenoma, 7; and adenocarcinoma, 9 (with mesenteric metastases, 3). The 5 bladder tumors were papillary or sessile transitional cell carcinomas.

1 Supported in part by Grants CA 14520 and CA 14524 through the National Bladder Cancer Project, and CA 20432. A preliminary report of this work has been made (13).

2 To whom requests for reprints should be addressed, at Division of Clinical Oncology, Department of Human Oncology, Wisconsin Clinical Cancer Center, University of Wisconsin Center for Health Sciences, K4/554 CSC, 600 Highland Avenue, Madison, Wis. 53792.

Received 9/13/79. Accepted 6/12/80.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
J. Brown, J. O'Prey, and P.R. Harrison
Enhanced sensitivity of human oral tumours to the flavonol, morin, during cancer progression: involvement of the Akt and stress kinase pathways
Carcinogenesis, February 1, 2003; 24(2): 171 - 177.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
G. von Krogh and E. Longstaff
Podophyllin office therapy against condyloma should be abandoned
Sex. Transm. Inf., December 1, 2001; 77(6): 409 - 412.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
E. Middleton Jr., C. Kandaswami, and T. C. Theoharides
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
Pharmacol. Rev., December 1, 2000; 52(4): 673 - 751.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Yang, S. A. Lamprecht, Y. Liu, H. Shinozaki, K. Fan, D. Leung, H. Newmark, V. E. Steele, G. J. Kelloff, and M. Lipkin
Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon
Carcinogenesis, September 1, 2000; 21(9): 1655 - 1660.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B. Ames
Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases
Science, September 23, 1983; 221(4617): 1256 - 1264.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.